Hence, we assumed that ERRα specific inverse agonist XCT790 would sensitize PC cells to gemcitabine, thus the combination of gemcitabine and XCT790 may exert synergistic cytotoxicity in PC cells. Here, ESRRA is linked to pachyonychia congenita.